← Back to Search

Showmotion for Osteoarthritis

N/A
Recruiting
Led By Vikas Patel, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour
Awards & highlights
No Placebo-Only Group

Summary

This trial will help to establish a database of shoulder, hip, knee and spine kinematics and muscles activity from 60 healthy volunteers using an innovative platform, Showmotion.

Who is the study for?
This trial is for healthy individuals aged between 18 and 65 who can follow instructions and have given written consent. They should not be overweight (BMI over 30), pregnant, have had surgery on the joint of interest, or suffer from active infections.
What is being tested?
The study is testing Showmotion, an innovative platform to measure how joints and muscles in the shoulder, hip, knee, and spine move and work in healthy volunteers to establish a baseline for future clinical use.
What are the potential side effects?
Since this trial involves non-invasive monitoring with Showmotion rather than medication or invasive procedures, significant side effects are not expected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
range of motion

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ShowmotionExperimental Treatment1 Intervention
Performing an analysis requires the positioning of sensors on the patient's skin in predetermined positions, according to the related protocols. Each sensor positioned on patient's skin provides both raw data (accelerometer, magnetometer, gyroscope) and the orientation matrix, representing the orientation of the local System of Reference (SoR) with respect to a fixed SoR. A proprietary sensor-fusion algorithm allows provides an accurate estimate of the orientation, as assessed by stereo-photogrammetric system-based testing. Data from each sensor are sampled at 50 Hz and transferred wirelessly to a laptop with a proprietary software that processes the data according to the biomechanical model chosen for the analysis.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,806 Previous Clinical Trials
2,822,346 Total Patients Enrolled
12 Trials studying Osteoarthritis
786 Patients Enrolled for Osteoarthritis
Vikas Patel, MDPrincipal InvestigatorUniversity of Colorado, Denver

Media Library

Showmotion Clinical Trial Eligibility Overview. Trial Name: NCT04137835 — N/A
Osteoarthritis Research Study Groups: Showmotion
Osteoarthritis Clinical Trial 2023: Showmotion Highlights & Side Effects. Trial Name: NCT04137835 — N/A
Showmotion 2023 Treatment Timeline for Medical Study. Trial Name: NCT04137835 — N/A
~13 spots leftby Dec 2025